Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DURABLE: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and rEarrangements

NCT05987644 is registered in ClinicalTrials.gov with Joshua Palmer as lead sponsor.

NCT NCT05987644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05987644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DURABLE: Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and rEarrangements
Lead sponsor
Joshua Palmer
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 7, 2024
Completion date
February 28, 2029
Enrollment
56 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, lung cancer, nsclc